We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more
SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
| Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.26 | 3.30795484379 | 38.09 | 41.0584 | 36.4285 | 562754 | 38.43044804 | CS |
| 4 | -7.39 | -15.810868635 | 46.74 | 47.43 | 36.26 | 469688 | 40.37844963 | CS |
| 12 | -19.02 | -32.5852321398 | 58.37 | 60.02 | 36.26 | 423211 | 47.43250765 | CS |
| 26 | 9.86 | 33.4350627331 | 29.49 | 72.29 | 27.05 | 547642 | 51.34902885 | CS |
| 52 | 17.85 | 83.023255814 | 21.5 | 72.29 | 14.19 | 443663 | 40.29041699 | CS |
| 156 | 17.85 | 83.023255814 | 21.5 | 72.29 | 14.19 | 443663 | 40.29041699 | CS |
| 260 | 17.85 | 83.023255814 | 21.5 | 72.29 | 14.19 | 443663 | 40.29041699 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
